Results 101 to 110 of about 37,598 (173)

Clinical effectiveness and impact of 13-valent pneumococcal conjugate vaccines in preventing invasive pneumococcal disease among children with risk conditions: A systematic literature review. [PDF]

Hum Vaccin Immunother
Hayford K, Tort MJ, Huang L, Forbes C, Pustulka I, Chapman R, Theilacker C.   +6 more
europepmc   +1 more source

Molecular Epidemiology, Antimicrobial Resistance, and Clinical Characteristics of <i>Streptococcus pneumoniae</i> Isolated from Adult Patients with Invasive Pneumococcal Disease. [PDF]

Antibiotics (Basel)
Franjić Amančić K, Mohar-Vitezić B, Cekinović Grbeša Đ, Grubić Kezele T, Abram M, Bubonja-Šonje M.   +5 more
europepmc   +1 more source

Economic burden of invasive pneumococcal disease in hospitalized children in Zhejiang Province, China: A multicenter hospital-based study conducted from 2014-2024. [PDF]

Hum Vaccin Immunother
Lu ZJ, Zhou JS, Zhu YY, Yang JH, Fang C, Zhou MM, Li XY, Liu SS, Liu Y, Hua CZ.   +9 more
europepmc   +1 more source

Two Outbreaks of Invasive Pneumococcal Disease in Nursing Homes in Gipuzkoa, Northern Spain. [PDF]

Vaccines (Basel)
Marimón JM, Manzanal A, Mokoroa O, Alvarez L, Rekalde M, Vicente D.   +5 more
europepmc   +1 more source

Effectiveness of a Single Dose of Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Children: A Systematic Literature Review. [PDF]

Infect Dis Ther
Dunne EM, Hong L, Althouse BM, Hayford K, Jodar L, Gessner BD, Theilacker C.   +6 more
europepmc   +1 more source

Antimicrobial resistance of Streptococcus pneumoniae from invasive pneumococcal disease in Brazil. [PDF]

Crit Care Sci
Kurtz P, Peloso PFD, Bozza FA.
europepmc   +1 more source

Pneumococcal serotypes and their association with death risk in invasive pneumococcal disease: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Darkwah S, Somda NS, Mahazu S, Donkor ES.   +3 more
europepmc   +1 more source

Influence of area-level social vulnerability on all-cause pneumonia, all-cause acute otitis media, and invasive pneumococcal disease incidence among Medicaid-enrolled children. [PDF]

Pneumonia (Nathan)
Mohanty S, Barna M, Cassell K, Cossrow N, Fiduccia PC, Smith-Howell E, McGuinn VC, Evans A, Keshaviah A, Shanmugam P, Chatrath S, Delannoy C, Feemster KA, Weissburg L, Zurovac J.   +14 more
europepmc   +1 more source

Clinical manifestations, serotype distribution, and incidence of pediatric invasive pneumococcal disease in Catalonia (Spain), 2018-2022. [PDF]

Eur J Pediatr
de Sevilla MF, Alcaraz-Soler C, Soldevila N, Izquierdo C, Esteva C, Moraga-Llop F, González-Peris S, Ciruela P, Díaz-Conradi A, Pérez-Argüello A, Viñado B, Domínguez A, García-García JJ, Muñoz-Almagro C.   +13 more
europepmc   +1 more source

S100A8/9-NLRP3-mediated chronic unresolved inflammation drives cardiac pathologies following invasive pneumococcal disease. [PDF]

Exp Mol Med
Tousif S, Minassian D, He C, Singh B, Umbarkar P, Bhati AS, Mohasin M, Erdmann N, Xie M, Sethu P, Orihuela CJ, Lal H.   +11 more
europepmc   +1 more source